Detalles de la búsqueda
1.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.
Br J Haematol
; 202(4): 749-759, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36257914
2.
Cost-Effectiveness of Cemiplimab Versus Standard of Care in the United States for First-Line Treatment of Advanced Non-small Cell Lung Cancer With Programmed Death-Ligand 1 Expression ≥50.
Value Health
; 25(2): 203-214, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35094793
3.
Systematic literature review and network meta-analysis of pembrolizumab versus other interventions for previously untreated, unresectable or metastatic, MSI-high or MMR-deficient CRC.
Future Oncol
; 18(17): 2155-2171, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35332802
4.
Assessing the Value of Cemiplimab for Adults With Advanced Cutaneous Squamous Cell Carcinoma: A Cost-Effectiveness Analysis.
Value Health
; 24(3): 377-387, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33641772
5.
Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma.
Future Oncol
; 17(5): 611-627, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33052055
6.
Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma.
Biol Blood Marrow Transplant
; 26(9): 1581-1588, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32561336
7.
Response to Letter to Editor Regarding "Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma".
Biol Blood Marrow Transplant
; 26(12): e335-e336, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32950694
8.
Penile cancer treatment costs in England.
BMC Public Health
; 15: 1305, 2015 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26715043
9.
Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis.
BMC Cancer
; 14: 968, 2014 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25515630
10.
The cost of anal cancer in England: retrospective hospital data analysis and Markov model.
BMC Public Health
; 14: 1123, 2014 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-25361522
11.
Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review.
PLoS One
; 19(6): e0303560, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38870136
12.
Outcomes of patients aged ≥26 years with relapsed or refractory B-cell acute lymphoblastic leukemia in ZUMA-3 and historical trials.
Leuk Lymphoma
; : 1-10, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38785408
13.
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor.
Adv Ther
; 41(5): 1938-1952, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38494543
14.
Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.
Leuk Lymphoma
; 65(1): 14-25, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37840282
15.
Matching-Adjusted Indirect Comparisons of Brexucabtagene Autoleucel with Alternative Standard Therapies for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients.
Adv Ther
; 40(12): 5383-5398, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801234
16.
Correlation Between Early Time-to-Event Outcomes and Overall Survival in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiation Therapy: Systematic Review and Meta-Analysis.
Front Oncol
; 12: 868490, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35574411
17.
Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50.
Ther Adv Med Oncol
; 14: 17588359221105024, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35747163
18.
Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer.
Front Oncol
; 12: 1081729, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-37082098
19.
Matching-adjusted indirect comparison of axi-cel and liso-cel in relapsed or refractory large B-cell lymphoma.
Leuk Lymphoma
; 63(13): 3052-3062, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36048026
20.
Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis.
Expert Rev Gastroenterol Hepatol
; 15(6): 711-722, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33599181